In a subsequent, but larger, Finnish study, RAD51C mutations were identified in ovarian cancer families only [100], while in a recent Spanish study, identified RAD51C mutations in 1.3% of breast and ovarian cancer families, with mutations in families with breast cancer cases only, were rare [101]. This evidence concerns the gene RAD51C and ovarian cancer.